Read more
3:17 PM · 19 July 2024

Netflix with a sharp increase in new subscribers 💡

Shares of Netflix (NFLX.US) are losing 0.5% before the opening of the Wall Street session, following the release of its Q2 2024 results. Although the results themselves turned out to be very good, with the company beating expectations in terms of the number of new subscribers, earnings per share and revenue, so forecasts for Q3 turned out to be slightly lower. 

Q2 RESULTS 

  • Net change in paid streaming subscriptions +8.05 million, +37% y/y, estimate +4.87 million
  • Revenue $9.56 billion, +17% y/y, estimate $9.53 billion 
  • Total paid streaming subscriptions 277.65 million, +16% y/y, estimate 273.78 million 
  • EPS $4.88 vs. $3.29 y/y, $4.74 estimate 
  • Operating margin 27.2% vs. 22.3% y/y, 26.5% estimate 
  • Operating income $2.60 billion, +42% y/y, $2.54 billion estimate 
  • Free cash flow $1.21 billion, -9.4% y/y, $1.61 billion estimate

THIRD QUARTER FORECAST 

  • Anticipates revenue $9.73 billion, estimate $9.83 billion 
  • Anticipates EPS $5.10, estimate $4.74 
  • Anticipates operating margin 28.1%, estimate 25.7%

FORECAST FOR THE YEAR 

  • Expects operating margin of 26%, previously 25%, estimate 25% 
  • Still anticipates free cash flow of about $6 billion, $6.59 billion estimate
  • Company anticipates annual revenue growth of 14%-15%, previously 13%-15% 

OTHER IMPORTANT COMMENTS

Advertising revenue is growing satisfactorily and becoming a more significant contributor to the business, but does not see advertising as a major driver of revenue growth in 2024 or 2025 

The company's shares lost nearly 0.5% before Wall Street opened. Source: xStation 5


 

 

24 April 2026, 6:40 PM

US Open: Nasdaq surges as semiconductor stocks improve sentiments on Wall Street

24 April 2026, 5:49 PM

🚩Avid Budget meme stock sinks as panic ended the 600% surge

24 April 2026, 4:45 PM

Market Wrap: Indices try to recover on US-Iran negotiations hopes 🇪🇺 SAP surges 6% after earnings 📈

24 April 2026, 1:13 PM

Intel: AI drives results, and CPUs may be the next stage of the revolution

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.